ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email!
Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014 Published on July 2014
Report Summary Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, 'Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014" provides data on the Obsessive-Compulsive Disorder clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Obsessive-Compulsive Disorder. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Obsessive-Compulsive Disorder. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Content Table of Contents Table of Contents 2 Introduction 6 Obsessive-Compulsive Disorder 6 Report Guidance 6
Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 1/7
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Clinical Trials by Region 7 Clinical Trials and Average Enrollment by Country 8 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Unaccomplished Trials of Obsessive-Compulsive Disorder 25 Subjects Recruited Over a Period of Time 27 Clinical Trials by Sponsor Type 28 Prominent Sponsors 29 Top Companies Participating in Obsessive-Compulsive Disorder Therapeutics Clinical Trials 30 Prominent Drugs 32 Clinical Trial Profiles 33 Clinical Trial Overview of Top Companies 33 F. Hoffmann-La Roche Ltd. 33 Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 33 Pfizer Inc. 34 Clinical Trial Overview of Pfizer Inc. 34 AstraZeneca PLC 35 Clinical Trial Overview of AstraZeneca PLC 35 H. Lundbeck A/S 36 Clinical Trial Overview of H. Lundbeck A/S 36 Novartis AG 37 Clinical Trial Overview of Novartis AG 37 Eli Lilly and Company 38 Clinical Trial Overview of Eli Lilly and Company 38 Meiji Seika Pharma Co., Ltd. 39 Clinical Trial Overview of Meiji Seika Pharma Co., Ltd. 39 GlaxoSmithKline plc 40 Clinical Trial Overview of GlaxoSmithKline plc 40 Abbott Laboratories 41 Clinical Trial Overview of Abbott Laboratories 41 Clinical Trial Overview of Top Institutes / Government 42 National Institute of Mental Health 42 Clinical Trial Overview of National Institute of Mental Health 42 University of South Florida 43 Clinical Trial Overview of University of South Florida 43
Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 2/7
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Massachusetts General Hospital 44 Clinical Trial Overview of Massachusetts General Hospital 44 The Sheba Medical Center 45 Clinical Trial Overview of The Sheba Medical Center 45 New York State Psychiatric Institute 46 Clinical Trial Overview of New York State Psychiatric Institute 46 University of California, Los Angeles 47 Clinical Trial Overview of University of California, Los Angeles 47 University of Sao Paulo 48 Clinical Trial Overview of University of Sao Paulo 48 Tehran University of Medical Sciences 49 Clinical Trial Overview of Tehran University of Medical Sciences 49 Duke University 50 Clinical Trial Overview of Duke University 50 University of Florida 51 Clinical Trial Overview of University of Florida 51 Five Key Clinical Profiles 52 Appendix 77 Abbreviations 77 Definitions 77 Research Methodology 78 Secondary Research 78 About GlobalData 79 Contact Us 79 Disclaimer 79 Source 79 List of Tables
Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Region, 2014* 7 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, North America, Top Countries, 2014* 12 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14 Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15 Obsessive-Compulsive Disorder Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16 Obsessive-Compulsive Disorder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17 Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18 Obsessive-Compulsive Disorder Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19 Obsessive-Compulsive Disorder Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Phase, 2014* 21 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 3/7
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Obsessive-Compulsive Disorder Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25 Obsessive-Compulsive Disorder Therapeutics, Global, Terminated Clinical Trials, 2014* 26 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27 Obsessive-Compulsive Disorder Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 33 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 34 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 35 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2014* 36 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 37 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 38 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Meiji Seika Pharma Co., Ltd., 2014* 39 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 40 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 41 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 42 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of South Florida, 2014* 43 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 44 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by The Sheba Medical Center, 2014* 45 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by New York State Psychiatric Institute, 2014* 46 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014* 47 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014* 48 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 49 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 50 Obsessive-Compulsive Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2014* 51 List of Figures
Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Region (%), 2014* 7 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14 Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15 Obsessive-Compulsive Disorder Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16 Obsessive-Compulsive Disorder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17 Proportion of Obsessive-Compulsive Disorder to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18 Obsessive-Compulsive Disorder Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 4/7
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Obsessive-Compulsive Disorder Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22 Obsessive-Compulsive Disorder Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27 Obsessive-Compulsive Disorder Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30 Obsessive-Compulsive Disorder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32 GlobalData Methodology 78
Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 5/7
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ
Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information Please verify that the product information is correct and select the format(s) you require. Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014
Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 500.00
Quantity: _____
Site License--USD 5 000.00
Quantity: _____
Corporate License--USD 7 500.00
Quantity: _____
Contact Information Please enter all the information below in BLOCK CAPITALS
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
First Name:
_____________________________ Last Name: __________________________________
Email Address:
__________________________________________________________________________
Job Title:
__________________________________________________________________________
Organization:
__________________________________________________________________________
Address:
__________________________________________________________________________
City:
__________________________________________________________________________
Postal / Zip Code:
__________________________________________________________________________
Country:
__________________________________________________________________________
Phone Number:
__________________________________________________________________________
Fax Number:
__________________________________________________________________________
Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 6/7
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card
Card Number: ______________________________________________
Expiry Date
__________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer
Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check
UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms
Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 7/7